W. Helfrich
发表
R. Dierckx,
P. Elsinga,
G. Carlucci,
2013,
Molecular pharmaceutics.
S. Rosati,
J. Pruim,
Xiaoyuan Chen,
2013,
Nuclear medicine and biology.
H. Wajant,
A. Rybczynska,
H. Nijman,
2014,
Molecular Cancer.
S. Barth,
W. Helfrich,
S. Chetty,
2017,
Biomedicines.
F. Kiessling,
R. Fischer,
A. Pardo,
2016,
Cancer letters.
F. Kiessling,
R. Fischer,
G. Fey,
2016,
International Journal of Cancer.
R. Fischer,
T. Thepen,
S. Barth,
2014,
Molecular Cancer Therapeutics.
Janko Kos,
Elena Reddi,
J. Kos,
2012,
Nanomedicine.
L. de Leij,
N. Mulder,
E. de Vries,
1997,
British Journal of Cancer.
C. Kallenberg,
H. Wajant,
W. Armbrust,
2011,
Immunology letters.
B. Feringa,
W. Szymański,
P. Elsinga,
2020,
Chemistry.
T. Bijma,
W. Helfrich,
Douwe F Samplonius,
2007,
Leukemia.
W. Helfrich,
E. Bremer,
V. R. Wiersma,
2013,
Medicinal research reviews.
T. Niki,
R. V. van Ginkel,
M. Hirashima,
2015,
Autophagy.
W. Oyen,
P. Mulders,
O. Boerman,
2012,
The Prostate.
Jia Newcombe,
Janet E. Holley,
J. Newcombe,
2014,
Multiple sclerosis and related disorders.
W. Helfrich,
E. Bremer,
2014,
Methods in molecular biology.
L. de Leij,
W. Helfrich,
E. Bremer,
2006,
Blood.
H. Wajant,
G. Fey,
A. A. van de Loosdrecht,
2008,
Cancer research.
P. Eggleton,
W. Helfrich,
R. J. Ginkel,
2014,
British journal of haematology.
R. Fischer,
G. Fey,
A. Pardo,
2014,
Cancer letters.
K. Kok,
S. Hu,
M. Ruiters,
2000,
International journal of cancer.
W. Helfrich,
E. Bremer,
V. R. Wiersma,
2017
.
H. Boezen,
H. Boezen,
T. Daemen,
2009,
The Cochrane database of systematic reviews.
T. Logtenberg,
G. Huls,
I. Heijnen,
1999,
Nature Biotechnology.
W. Helfrich,
Douwe F Samplonius,
Iris Koopmans,
2020,
Oncoimmunology.
W. Helfrich,
R. V. Ginkel,
E. Bremer,
2017
.
B. Emmerich,
G. Fey,
M. Peipp,
2008,
Cancer Immunology, Immunotherapy.
B. Kroesen,
G. Molema,
D. Meijer,
2000,
Journal of controlled release : official journal of the Controlled Release Society.
G. Huls,
W. Helfrich,
E. Bremer,
2010
.
T. Bijma,
G. Fey,
G. Huls,
2009,
Leukemia.
R. Dierckx,
E. Vries,
P. Elsinga,
2021
.
A. van Waarde,
R. Dierckx,
P. Elsinga,
2021,
The Journal of Nuclear Medicine.
W. Helfrich,
J. Kuijlen,
W. Dunnen,
2007,
Journal of neuro-oncology.
G. V. van Dam,
H. Haisma,
W. Helfrich,
2008,
Molecular therapy : the journal of the American Society of Gene Therapy.
T. Bijma,
W. Helfrich,
E. Bremer,
2008,
Journal of Molecular Medicine.
P. Vos,
W. Helfrich,
J. Kuijlen,
2005,
Journal of Neuro-Oncology.
B. Kroesen,
W. Helfrich,
E. Bremer,
2004,
Neoplasia.
H. Walczak,
W. Helfrich,
J. Kuijlen,
2004,
International journal of cancer.
R. V. van Ginkel,
W. Helfrich,
E. Bremer,
2016,
Oncoimmunology.
H. Nijman,
W. Helfrich,
E. Bremer,
2015,
mAbs.
W. Helfrich,
E. Bremer,
2015
.
W. Helfrich,
E. Bremer,
M. de Bruyn,
2013,
Cancer letters.
Fan Wang,
R. Dierckx,
P. Elsinga,
2013,
Current pharmaceutical design.
G. Fleuren,
G. Riethmüller,
W. Helfrich,
2017
.
G. Fleuren,
G. Riethmüller,
I. B. Briaire-de Bruijn,
2001,
Molecular and Cellular Biology.
G. Fleuren,
G. Riethmüller,
W. Helfrich,
2001
.
R. V. van Ginkel,
S. Heskamp,
W. Helfrich,
2018,
Oncoimmunology.
Yichen Luo,
W. Helfrich,
Yusheng Lin,
2022,
Journal of extracellular vesicles.
T. Niki,
R. V. van Ginkel,
M. Hirashima,
2013,
PloS one.
P. Eggleton,
W. Helfrich,
E. Bremer,
2015,
Front. Oncol..
W. Helfrich,
E. Bremer,
L. Leij,
2006
.
R. V. van Ginkel,
W. Helfrich,
E. Bremer,
2019,
The Journal of investigative dermatology.
T. Niki,
R. V. van Ginkel,
M. Hirashima,
2012,
The Journal of investigative dermatology.
B. Kroesen,
G. Molema,
R. Roovers,
1998,
International journal of cancer.
L. de Leij,
B. Kroesen,
T. The,
1996,
British Journal of Cancer.
R. Henning,
D. Zeeuw,
D. de Zeeuw,
2008,
Kidney international.
W. Oyen,
W. Mcbride,
O. Boerman,
2014,
Cancer research.
R. Rink,
G. Moll,
R. Dierckx,
2015,
Peptides.
R. V. van Ginkel,
S. Kruijff,
L. Been,
2022,
BJS open.
R. Henning,
D. de Zeeuw,
H. van Goor,
2007,
The journal of gene medicine.
R. V. van Ginkel,
G. Huls,
W. Helfrich,
2017,
Oncoimmunology.
W. Helfrich,
E. Bremer,
Yuan He,
2018,
Methods in molecular biology.
Weihui Zhang,
W. Helfrich,
E. Bremer,
2015
.
Weihui Zhang,
W. Helfrich,
E. Bremer,
2010,
BMC gastroenterology.
H. Haisma,
W. Helfrich,
K. Poelstra,
2014,
The journal of gene medicine.
H. Haisma,
W. Helfrich,
K. Poelstra,
2014
.
B. Kroesen,
H. Kal,
T. The,
1995,
International journal of cancer.
H. Wajant,
A. Rybczynska,
H. Nijman,
2018
.
W. Helfrich,
E. Bremer,
Yuan He,
2016
.
H. Wajant,
A. Rybczynska,
H. Nijman,
2014
.
H. Groen,
L. de Leij,
E. de Vries,
1997,
Cancer Immunology, Immunotherapy.
Baofeng Yang,
A. V. D. Van Der Zee,
H. Klip,
2011,
Clinical Cancer Research.
S. Goerdt,
H. Augustin,
J. Kroll,
2008,
Hepatology.
B. Kroesen,
G. V. van Dam,
W. Helfrich,
2006,
Trends in molecular medicine.
M. Peppelenbosch,
S. Al-lahham,
F. Johansen,
2008,
Molecular nutrition & food research.
B. Kroesen,
W. Helfrich,
E. Bremer,
2006
.
W. Helfrich,
Douwe F Samplonius,
D. Samplonius,
2021,
Oncoimmunology.
H. Boezen,
T. Daemen,
C. Melief,
2014,
The Cochrane database of systematic reviews.
W. Helfrich,
E. Bremer,
M. de Bruyn,
2010,
Current drug targets.
H. Ananias,
W. Helfrich,
I. D. de Jong,
2009,
The Prostate.
M. C. V. D. Heuvel,
H. Ananias,
W. Helfrich,
2009
.
Fan Wang,
R. Dierckx,
P. Elsinga,
2012,
Amino Acids.
W. Oyen,
O. Boerman,
S. Lütje,
2014,
Molecular Imaging and Biology.
R. V. van Ginkel,
W. Helfrich,
E. Bremer,
2016,
The Journal of investigative dermatology.
B. Kroesen,
W. Helfrich,
E. Bremer,
2017
.
H. Groen,
E. D. de Vries,
R. Fehrmann,
2018,
Oncogene.
B. Kroesen,
G. Molema,
W. Helfrich,
1998
.
N. Viner,
J. Tarr,
R. Haigh,
2011,
Arthritis research & therapy.
Giulio Fracasso,
Mark Rijpkema,
Susanne Lütje,
2014,
The Journal of Nuclear Medicine.
B. Kroesen,
G. Molema,
D. Meijer,
2000,
British Journal of Cancer.
H. Hollema,
H. Klip,
G. Wisman,
2017
.
H. Hollema,
H. Klip,
G. Wisman,
2016,
Oncotarget.
A. van Waarde,
A. Rybczynska,
G. Fey,
2010,
Molecular Cancer.
B. Kroesen,
W. Helfrich,
Douwe F Samplonius,
2005,
Journal of Biological Chemistry.
S. Withoff,
G. Molema,
W. Helfrich,
2001,
Current opinion in molecular therapeutics.
B. Kroesen,
S. Jacobs,
G. Molema,
2002,
International journal of cancer.
P. Terpstra,
M. Harmsen,
B. Kroesen,
2004,
Cancer Gene Therapy.
W. Helfrich,
E. Bremer,
Peter E. van Bommel,
2017,
Scientific Reports.
B. Feringa,
W. Szymański,
M. Stuart,
2019,
Chemical communications.
B. Kroesen,
T. Luther,
V. Magdolen,
2000,
Journal of immunological methods.
J. Arends,
R. Roovers,
H. Hoogenboom,
1998,
British Journal of Cancer.
A. van Waarde,
A. Rybczynska,
R. Dierckx,
2013,
The Journal of Nuclear Medicine.
B. Kroesen,
G. Molema,
D. Meijer,
1998,
Cytometry.
D. Spierings,
H. Kluin-Nelemans,
B. Kroesen,
2007,
The Journal of Immunology.
C. Van de Wiele,
R. Dierckx,
P. Elsinga,
2008,
Current pharmaceutical design.
S. Kruijff,
W. Helfrich,
D. Samplonius,
2021,
Cancer letters.
W. Helfrich,
E. Bremer,
J. Mooij,
2010,
Neuropathology and applied neurobiology.
W. Helfrich,
J. Kuijlen,
E. Bremer,
2010
.
W. Helfrich,
E. Bremer,
Iris Koopmans,
2017
.
W. Oyen,
A. Eek,
O. Boerman,
2015,
Contrast media & molecular imaging.
W. Helfrich,
L. de Leij,
Pepijn Wittop Koning,
1994,
International journal of cancer. Supplement = Journal international du cancer. Supplement.
Xiaoyuan Chen,
R. Dierckx,
P. Elsinga,
2011,
Molecular pharmaceutics.
B. Kroesen,
G. Fey,
M. Peipp,
2005,
Cancer research.
G. C. Langhout,
V Ntziachristos,
G. Themelis,
2011,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
B. Feringa,
W. Szymański,
R. Dierckx,
2022,
EJNMMI Radiopharmacy and Chemistry.
H. Boezen,
T. Daemen,
N. Leffers,
2010,
The Cochrane database of systematic reviews.
B. Kroesen,
W. Helfrich,
E. Bremer,
2022
.
W. Helfrich,
R. J. Ginkel,
E. Bremer,
2019
.
W. Helfrich,
D. Samplonius,
Xiurong Ke,
2023,
Oncoimmunology.
A. Pardo,
S. Barth,
W. Helfrich,
2013,
Current pharmaceutical design.
W. Helfrich,
Isabel Britsch,
A. V. van Wijngaarden,
2023,
Cancers.
H. Klip,
P. Eggleton,
H. Nijman,
2015,
Oncoimmunology.
A. Roebroek,
W. V. D. Van de Ven,
J. Kemshead,
1992,
International journal of cancer.
H. Wajant,
W. Helfrich,
E. Bremer,
2009,
Current drug targets.
B. Kroesen,
G. Molema,
Helfrich,
1998,
Advanced drug delivery reviews.
B. Kroesen,
W. Helfrich,
E. Bremer,
2006
.
B. Kroesen,
G. V. van Dam,
W. Helfrich,
2006,
Trends in molecular medicine.
W. Helfrich,
Mark,
D. Samplonius,
2023
.
W. Helfrich,
D. Samplonius,
Xiurong Ke,
2023,
Cancers.
W. Helfrich,
D. Samplonius,
Xiurong Ke,
2023,
Journal for ImmunoTherapy of Cancer.
W. Helfrich,
Douwe F Samplonius,
Iris Koopmans,
2023
.
D. Spierings,
H. Kluin-Nelemans,
B. Kroesen,
2007
.
T. Daemen,
N. Leffers,
H. Nijman,
2018,
The Cochrane database of systematic reviews.
H. Wajant,
G. Fey,
A. A. van de Loosdrecht,
2008,
Cancer research.
B. Kroesen,
W. Helfrich,
E. Bremer,
2004,
Neoplasia.
A. Eek,
S. Lütje,
G. Franssen,
2022
.
Max J H Witjes,
Jan L N Roodenburg,
Sebastiaan de Visscher,
2014,
Lasers in surgery and medicine.
S. Liu,
H. Ananias,
Z. Yu,
2013,
Molecular pharmaceutics.
A. Arcovito,
A. Boffi,
F. Fazi,
2016
.
W. Helfrich,
E. Bremer,
D. Hendriks,
2017
.
W. Helfrich,
E. Bremer,
D. Samplonius,
2017
.
H. Haisma,
W. Helfrich,
K. Poelstra,
2014
.
R. Dierckx,
P. Elsinga,
G. Carlucci,
2013,
Amino Acids.